Close Menu

Synthetic Ethics

Amy Gutmann tells The Scientist that the US presidential commission on bioethics looked for the "Aristotelian mean" between a no-holds-barred approach to synthetic biology and one that prevents the field from moving forward until all risk is removed. "We're likely to recommend that new organisms when they're created should be marked or branded in some manner to be able to monitor development in synthetic biology," Gutmann says, adding that there are multiple ways of doing so.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.